Italy joins other EU countries list, recognises India's Covishield vaccine

New Delhi, September 24: Joining the other European countries, Italy has officially recognised India's Covishield vaccine manufactured by Pune-based Serum Institute of India (SII) as a COVID-19 vaccine. With that recognition, Indian vaccine cardholders are now eligible for GreenPass.

 

 

This comes amid the row with the United Kingdom over the recognition of the Covishield vaccine. The Embassy of India in Italy has informed about the fabulous development. In the tweet, the country has recognised India's Covishield COVID-19 vaccine.

 

This development comes after the G-20 Health Ministers' meeting between India's Health Minister Mansukh Mandaviya and his Italian counterpart Roberto Speranza. In addition, the outcome is also a result of the efforts taken by India's External Affairs Ministry and Italy's Ministry of Health, the Embassy added.

 

 

 

 

Until now, Italy had only recognised these Covid-19 vaccines--Comirnaty – Pfizer; Moderna; Vaxzervria – AstraZeneca, and Janssen – Johnson & Johnson for travel.

 

Now, a total of 19 countries have recognised the Covishield vaccine, these include Austria, Belgium, Bulgaria, Croatia, Finland, Germany, Greece, Hungary, Iceland, Ireland, Latvia, Netherlands, Romania, Slovenia, Spain, Sweden, and Switzerland.

 

 

Covishield, which is the AstraZeneca vaccine produced in India, is the most widely recognised vaccine for travel in the EU after those approved by EMA.